Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion | PLOS ONE
Metronomic cyclophosphamide therapy in hormone-naive patients with non-metastatic biochemical recurrent prostate cancer: a phase II trial | SpringerLink
Impact of metronomic cyclophosphamide (mCy) on regulatory T cells over... | Download Scientific Diagram
Metronomic cyclophosphamide‑induced long‑term remission after recurrent high‑grade serous ovarian cancer: A case study
Low-dose “metronomic chemotherapy” with oral cyclophosphamide and methotrexate in metastatic breast cancer: a case report of extraordinarily prolonged clinical
Cyclophosphamide - Wikipedia
Anti-tumor innate immunity activated by intermittent metronomic cyclophosphamide treatment of 9L brain tumor xenografts is preserved by anti-angiogenic drugs that spare VEGF receptor 2 | Molecular Cancer | Full Text
Oral Metronomic Cyclophosphamide with and without Methotrexate as Palliative Treatment for Patients with Metastatic Breast Carcinoma | Anticancer Research
Metronomic Maintenance for High-Risk Pediatric Malignancies: One Size Will Not Fit All: Trends in Cancer
Pazopanib based oral metronomic therapy for platinum resistant/refractory epithelial ovarian cancer: A phase II, open label, randomized, controlled trial - Gynecologic Oncology
Functional and pharmacodynamic evaluation of metronomic cyclophosphamide and docetaxel regimen in castration-resistant prostate cancer | Future Oncology
Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity - Annals of Oncology
Metronomic Chemotherapy: Direct Targeting of Cancer Cells after all?: Trends in Cancer
A) Single low-dose cyclophosphamide is superior to metronomic... | Download Scientific Diagram
Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers | EMBO Molecular Medicine
Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer | npj Breast Cancer
Cancers | Free Full-Text | Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment | HTML
Metronomic cyclophosphamide activation of anti-tumor immunity: tumor model, mouse host, and drug schedule dependence of gene responses and their upstream regulators | BMC Cancer | Full Text
Metronomic Oral Cyclophosphamide Prednisolone Chemotherapy Is an Effective Treatment for Metastatic Hormone-refractory Prostate Cancer after Docetaxel Failure | Anticancer Research
Therapeutic efficacy of metronomic chemotherapy with cyclophosphamide and doxorubicin on murine mammary adenocarcinomas - Annals of Oncology
Metronomic oral cyclophosphamide in relapsed ovarian cancer | International Journal of Gynecologic Cancer
Cyclophosphamide - Wikipedia
Metronomic Cyclophosphamide with Cisplatin and Bevacizumab: A New Chemotherapeutic Regimen for Refractory Anaplastic Ependymoma | Anticancer Research
Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate | British Journal of Cancer
Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer | npj Breast Cancer
